Dynavax to Present at the Cowen 40th Annual Health Care Conference

EMERYVILLE, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the Cowen 40th Annual Health Care Conference on Monday, March 2, at 1:30 p.m. E.T.

The presentation will be webcast and may be accessed through the “Events & Presentations” page on the “investors” section of the Company’s website at http://investors.dynavax.com/events-presentations.

About DynavaxDynavax is a commercial stage biopharmaceutical company developing and commercializing novel vaccines. The Company launched its first commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant), Adjuvanted], in February 2018, following U.S. FDA approval for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older.  For more information, visit www.dynavax.com and follow the company on LinkedIn.

Contacts:

Nicole Arndt[email protected]510-665-7264

Derek Cole, President Investor Relations Advisory Solutions[email protected]

Source: Dynavax Technologies Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Anmodning om ophør af suspension i enkelte afdelinger under Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select
• Airia and Nephos Technologies announce strategic partnership to close gap between AI platform control and data governance
• Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress